Beyond MACE: a multidimensional approach to outcomes in clinical trials for older adults with stable ischemic heart

Kriti Kalra1, Mohamad B Moumneh1, Michael G Nanna2

  • 1Inova Center of Outcomes Research, Inova Heart and Vascular, Fairfax, VA, United States.

PubMed

Insights

Managing stable ischemic heart disease (SIHD) in older adults requires a patient-centered approach. Focusing on holistic health outcomes and individual needs improves care for this high-risk population.

Area of Science:

  • Gerontology
  • Cardiology
  • Geriatric Medicine

Background:

  • The global population of older adults is rapidly expanding, leading to an increase in multiple chronic diseases, often exacerbated by cardiovascular conditions.
  • Stable ischemic heart disease (SIHD) is a major cause of illness and death in older adults.
  • Current SIHD management is suboptimal due to underrepresentation of older adults in clinical trials and insufficient consideration of biological aging, geriatric syndromes, and patient preferences.

Purpose of the Study:

  • To highlight the unique health needs of older adults with SIHD.
  • To advocate for a patient-centered approach that prioritizes holistic outcomes like functional capacity, cognitive health, mental well-being, and quality of life.
  • To emphasize the importance of shared decision-making in treatment strategies for older adults.

Main Methods:

  • This is a review article.
  • It synthesizes current understanding of SIHD management in older adults.
  • It focuses on the intersection of aging, chronic disease, and patient-centered care.

Main Results:

  • Older adults have distinct needs that go beyond traditional cardiovascular outcomes.
  • Holistic health outcomes (functional capacity, cognition, mental health, quality of life) are crucial for this population.
  • An individualized, patient-centered approach is essential for effective SIHD management.

Conclusions:

  • A shift towards patient-centered care and shared decision-making is necessary for managing SIHD in older adults.
  • Addressing the unique needs of older adults promotes successful aging and improves cardiovascular care.
  • Prioritizing patient preferences alongside clinical outcomes leads to more effective management of SIHD in the highest-risk population.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
168
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130